NasdaqGS - Nasdaq Real Time Price • USD
XBiotech Inc. (XBIT)
As of 11:40 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2020) | Next Qtr. (Sep 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.16 | -0.15 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2020) | Next Qtr. (Sep 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 7M | 7M | 44M | 28M |
| Low Estimate | 7M | 7M | 28M | 28M |
| High Estimate | 7M | 7M | 28M | 28M |
| Year Ago Sales | -- | -- | -- | 44M |
| Sales Growth (year/est) | -- | -- | -- | -36.40% |
Earnings History
| CURRENCY IN USD | 6/30/2019 | 9/30/2019 | 12/31/2019 | 3/31/2020 |
|---|---|---|---|---|
| EPS Est. | -0.15 | -0.15 | -0.15 | 0.06 |
| EPS Actual | -0.16 | -0.15 | 14.59 | 0 |
| Difference | -0.01 | 0 | 14.74 | -0.06 |
| Surprise % | -6.70% | 0.00% | 9,826.70% | -100.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2020) | Next Qtr. (Sep 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0.04 | 0.04 | 0.19 | 0.13 |
| 30 Days Ago | 0.04 | 0.04 | 0.19 | 0.13 |
| 60 Days Ago | 0.04 | 0.04 | 0.19 | 0.13 |
| 90 Days Ago | 0.04 | 0.04 | 0.19 | 0.13 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2020) | Next Qtr. (Sep 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | XBIT | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 11.40% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Piper Sandler: Overweight | 4/7/2020 |
| Maintains | Piper Sandler: Overweight | 12/11/2019 |
| Initiated | Piper Sandler: Overweight | 6/14/2019 |
Related Tickers
XLS.SW Xlife Sciences AG
34.00
-1.16%
BION.SW BB Biotech AG Ord
40.35
-2.65%
EWTX Edgewise Therapeutics, Inc.
15.38
-4.56%
HOWL Werewolf Therapeutics, Inc.
6.01
-5.95%
STTK Shattuck Labs, Inc.
9.60
-3.03%
ASMB Assembly Biosciences, Inc.
13.17
-2.08%
MGTX MeiraGTx Holdings plc
4.6800
-3.70%
CYCN Cyclerion Therapeutics, Inc.
2.8700
+1.41%
NWRN.SW Newron Pharmaceuticals S.p.A.
6.81
-2.71%
HLVX HilleVax, Inc.
11.90
-5.41%